Suppr超能文献

[关于血清中α-间胰蛋白酶抑制剂的降解产物。II. α-间胰蛋白酶抑制剂的酸性标记衍生物(作者译)]

[About degradation products of the inter-alpha-trypsin inhibitor in serum. II. Acid label derivatives of the inter-alpha-trypsin inhibitor (author's transl)].

作者信息

Hochstrasser K, Niebel J, Lempart K

出版信息

Klin Wochenschr. 1977 Apr 1;55(7):343-5. doi: 10.1007/BF01488113.

Abstract

Simultaneous to the liberation of the acid stable trypsin-plasmin-inhibitor from the inter-alpha-trypsininhibitor in vivo, acid labile degradation products are set free. The main product can be estimated by immunological methods. This product is not excreted by the kidney in contrast to the acid stable inhibitor. The product accumulates in serum in different diseases. An increased concentration of this product indicates also an increased turn-over of the inter-alpha-trypsin inhibitor in the case when the concentraton of the intact inter-alpha-trypsin inhibitor or of the filtrable derivative are within normal range.

摘要

在体内,与从α-胰蛋白酶抑制剂中释放出酸稳定的胰蛋白酶-纤溶酶抑制剂同时,酸不稳定的降解产物也被释放出来。主要产物可用免疫学方法进行评估。与酸稳定抑制剂不同,该产物不会经肾脏排泄。该产物在不同疾病的血清中会蓄积。当完整的α-胰蛋白酶抑制剂或可滤过衍生物的浓度在正常范围内时,该产物浓度的升高也表明α-胰蛋白酶抑制剂的周转率增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验